🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to determine the safety, tolerabilit...
Status
Completed
Location
USC Norris Hospital and Clinics
Start Date
2018-07-25
Trial ID
NCT03517956
Treatments Being Tested
This phase II trial studies the effect of rogaratinib in treating patients ...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-05-03
Trial ID
NCT04595747
FORT-2 is designed to evaluate safety, efficacy, RP2D and PK of rogaratinib...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2018-05-15
Trial ID
NCT03473756
Treatments Being Tested
The purpose of this study is to enable patients, who are currently receivin...
Status
Completed
Location
Kantonsspital St. Gallen
Start Date
2019-10-30
Trial ID
NCT04125693
Treatments Being Tested
This study is planned to determine the safety and tolerability of rogaratin...
Status
Completed
Location
Beijing Hospital
Start Date
2019-01-07
Trial ID
NCT03788603
Treatments Being Tested
This is a randomized, open-label, multicenter Phase 2/3 study to evaluate t...
Status
Completed
Location
Alaska Clinical Research Center, LLC
Start Date
2018-05-31
Trial ID
NCT03410693
Treatments Being Tested
A recent investigation showed that a substantial proportion of patients wit...
Status
Terminated
Location
Kantonsspital Baden
Start Date
2019-07-25
Trial ID
NCT03762122
Treatments Being Tested
The objective of this study is to determine the mass balance and routes of ...
Status
Completed
Location
PRAHealthSciences
Start Date
2018-04-06
Trial ID
NCT03484585
Treatments Being Tested
* This was the first study where BAY1163877 was given to humans. Impact of ...
Status
Completed
Location
Multiple Locations
Start Date
2013-12-30
Trial ID
NCT01976741
Primary objectives of this study are to assess the safety and tolerability ...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-15
Trial ID
NCT02592785
Treatments Being Tested